Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richa Sharma

Showing results (271-280 of 342) with videos related to

Pageof 35
Sort By:
Molecular Oncology|May 31, 2021
SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cellsKa-Kui Chan, Zahi Abdul-Sater, Aditya Sheth, et al.
Biology Methods & Protocols|April 14, 2025
Digital pathology assessment of kidney glomerular filtration barrier ultrastructure in an animal model of podocytopathyAksel Laudon, Zhaoze Wang, Anqi Zou, et al.
NPJ Digital Medicine|May 17, 2024
StrokeClassifier: ischemic stroke etiology classification by ensemble consensus modeling using electronic health recordsHo-Joon Lee, Lee H Schwamm, Lauren H Sansing, et al.
Journal for Immunotherapy of Cancer|November 24, 2021
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapyLuis Enrique Munoz, Lei Huang, Ramireddy Bommireddy, et al.
Journal of the American Heart Association|April 19, 2024
Secondary Prevention in Patients With Stroke Versus Myocardial Infarction: Analysis of 2 National CohortsCyprien A Rivier, Julian N Acosta, Audrey C Leasure, et al.
Chemmedchem|May 12, 2020
Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer AgentsMohit K Tiwari, Paolo Coghi, Prakhar Agrawal, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 8, 2017
The Cedar Project: mortality among young Indigenous people who use drugs in British ColumbiaKate Jongbloed, Margo E Pearce, Sherri Pooyak, et al.
Stroke|September 2, 2025
Apixaban and Recurrent Stroke Risk With Left Ventricular Dysfunction: A Secondary Analysis of the ARCADIA TrialRicha Sharma, Dinesh Jillella, Cenai Zhang, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 29, 2021
Expedited and Comprehensive Management of Low-Risk TIA Patients in the Emergency Department is Safe and Less CostlyAnisha Garg, Ilavarasy Maran, Hardik Amin, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Biological Evaluation in Resistant Cancer Cells and Study of Mechanism of Action of Arylvinyl-1,2,4-TrioxanesJerome P L Ng, Mohit K Tiwari, Ali Adnan Nasim, et al.
Pageof 35

Showing results (271-280 of 342) with videos related to

Sort By:
Pageof 35
Molecular Oncology|May 31, 2021
SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cellsKa-Kui Chan, Zahi Abdul-Sater, Aditya Sheth, et al.
Biology Methods & Protocols|April 14, 2025
Digital pathology assessment of kidney glomerular filtration barrier ultrastructure in an animal model of podocytopathyAksel Laudon, Zhaoze Wang, Anqi Zou, et al.
NPJ Digital Medicine|May 17, 2024
StrokeClassifier: ischemic stroke etiology classification by ensemble consensus modeling using electronic health recordsHo-Joon Lee, Lee H Schwamm, Lauren H Sansing, et al.
Journal for Immunotherapy of Cancer|November 24, 2021
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapyLuis Enrique Munoz, Lei Huang, Ramireddy Bommireddy, et al.
Journal of the American Heart Association|April 19, 2024
Secondary Prevention in Patients With Stroke Versus Myocardial Infarction: Analysis of 2 National CohortsCyprien A Rivier, Julian N Acosta, Audrey C Leasure, et al.
Chemmedchem|May 12, 2020
Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer AgentsMohit K Tiwari, Paolo Coghi, Prakhar Agrawal, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 8, 2017
The Cedar Project: mortality among young Indigenous people who use drugs in British ColumbiaKate Jongbloed, Margo E Pearce, Sherri Pooyak, et al.
Stroke|September 2, 2025
Apixaban and Recurrent Stroke Risk With Left Ventricular Dysfunction: A Secondary Analysis of the ARCADIA TrialRicha Sharma, Dinesh Jillella, Cenai Zhang, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 29, 2021
Expedited and Comprehensive Management of Low-Risk TIA Patients in the Emergency Department is Safe and Less CostlyAnisha Garg, Ilavarasy Maran, Hardik Amin, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Biological Evaluation in Resistant Cancer Cells and Study of Mechanism of Action of Arylvinyl-1,2,4-TrioxanesJerome P L Ng, Mohit K Tiwari, Ali Adnan Nasim, et al.
Pageof 35